Daniel Khalaf, University of Toronto

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

STEAP1-targeted strategies in advanced prostate cancer: a review on therapeutic and diagnostic implications.
Prostate cancer and prostatic diseases · 2026
Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel.
Cancer investigation · 2026

All 2 publications

Latest funding

A type 1 hybrid effectiveness-implementation trial of a virtual exercise-based rehabilitation intervention for persistent chemotherapy induced peripheral neuropathy (EX-CIPN).
CIHR · 2026 · Co-investigator
$753,525
A pragmatic randomized controlled trial of a virtual exercise-based rehabilitation intervention for persistent chemotherapy-induced peripheral neuropathy (EX-CIPN).
CIHR · 2025 · Co-investigator
$100,000

All 2 grants and awards

2 publications.

01

STEAP1-targeted strategies in advanced prostate cancer: a review on therapeutic and diagnostic implications.

Heo JY, Sheng M, Khalaf D, Leong HS, Emmenegger U

Prostate cancer and prostatic diseases20261 citations

DOI: 10.1038/s41391-025-01038-8 PMID: 41131283

02

Prognostic Impact of TP53 and RB1 Alterations in Metastatic Castration-Resistant Prostate Cancer Treated with Docetaxel.

Heo JY, Lee C, Shin H, Cho S, Beom SH, Choi YD, Han WK, Ham WS, Jang WS, Han H, Lee J, Heo JE, Khalaf D, Emmenegger U, Kim S, Kim CG, Jung M, Shin SJ

Cancer investigation2026

DOI: 10.1080/07357907.2026.2672004 PMID: 42138020

A type 1 hybrid effectiveness-implementation trial of a virtual exercise-based rehabilitation intervention for persistent chemotherapy induced peripheral neuropathy (EX-CIPN).

Co-investigatorCIHR2026Project Grant

Principal investigators: Jones, Jennifer M; Langelier, David M; Nadler, Michelle

Keywords: Cancer; Chemotherapy-Induced Peripheral Neuropathy; Clinical Trial; Rehabilitation

$753,525

A pragmatic randomized controlled trial of a virtual exercise-based rehabilitation intervention for persistent chemotherapy-induced peripheral neuropathy (EX-CIPN).

Co-investigatorCIHR2025Project Grant - Priority Announcement - Cancer Survivorship

Principal investigators: Jones, Jennifer M; Langelier, David M; Nadler, Michelle

Keywords: Cancer; Chemotherapy-Induced Peripheral Neuropathy; Clinical Trial; Rehabilitation

$100,000

From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.

Frequent collaborators

Department of Medicine
Department of Medical Biophysics

Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.

Urban Emmenegger

Department of Medicine

2 shared papers, latest 2026

Hon Leong

Department of Medical Biophysics

1 shared papers, latest 2026

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mention

Subject: Prospective PhD student Dear Professor Khalaf, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "STEAP1-targeted strategies in advanced prostate cancer: a review on therapeutic and diagnostic implications." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]